Market Drivers and Barriers for Vascular Stents: An In-Depth Analysis

 


What are Vascular Stents?

Vascular stents are medical devices that are used to treat narrow or blocked blood vessels. They are small, mesh-like tubes that are inserted into the affected artery to help prop it open and improve blood flow. The global vascular stents market is expected to grow significantly in the coming years due to an increase in the prevalence of cardiovascular diseases, technological advancements in stent design, and the growing aging population.

Vascular Stents Market Size and Forecast

The global vascular stents market size is expected to reach USD 16.52 billion by 2028, growing at a CAGR of 6.7% from 2021 to 2028. North America dominates the market due to a high prevalence of cardiovascular diseases, increased healthcare spending, and better healthcare infrastructure.

Vascular Stents Market Trends and Analysis

The market is experiencing a shift towards the development of bioresorbable stents that dissolve within the body after the artery has healed. This reduces the risk of complications associated with permanent stents, such as restenosis and thrombosis.

Key Companies in the Vascular Stents Market

The key companies operating in the vascular stents market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical Inc., Medtronic plc, and Terumo Corporation. These companies are focused on developing innovative products to gain a competitive advantage and expand their market share.

Pipeline Therapies in the Vascular Stents Market

The vascular stents market is experiencing significant growth due to the development of new pipeline therapies. For instance, Bioabsorbable Magnesium Alloy Stent (BIOMAG), a bioresorbable stent, is being developed by REVA Medical, Inc. for the treatment of coronary artery disease.

Market Drivers for the Vascular Stents Market

Out of many other market drivers for vascular stents, the market is being driven by the increasing prevalence of cardiovascular diseases, rising demand for minimally invasive surgeries, and technological advancements in stent design.

Market Barriers for the Vascular Stents Market

The market is facing several challenges, the market barriers for Vascular Stents market includes the high cost of stent procedures, stringent regulatory policies, and a lack of skilled healthcare professionals.

Upcoming Trends in the Vascular Stents Market

The market is expected to witness an increase in the adoption of drug-eluting stents and a shift towards the development of bioresorbable stents. Moreover, there is an increasing focus on the development of stents with improved biocompatibility and reduced thrombogenicity.

Conclusion

The global vascular stents market is expected to grow significantly in the coming years due to the increasing prevalence of cardiovascular diseases and the growing aging population. The market is experiencing a shift towards the development of bioresorbable stents, and vascular stents key players are focused on developing innovative products to gain a competitive advantage. However, the market is facing several challenges, including the high cost of stent procedures and stringent regulatory policies. Despite these challenges, the vascular stents market is poised for significant growth in the coming years.


To know more about our Consulting Services, Click here: DelveInsight Healthcare Consulting


Related Reports by DelveInsight- 

scedosporium infection market | autoimmune pulmonary alveolar proteinosis market | rosai-dorfman disease market | sandhoff disease market | b-cell chronic lymphocytic leukemia market | bladder cancer market | trichomoniasis market | bile duct cancer market | resorbable vascular scaffold market | salivary gland infection market | ischemic stroke market | paget's disease market | ventricular assist devices market | vascular stents market | vascular graft devices market | bladder scanners market | b-cell non-hodgkin lymphoma market | basal cell carcinoma market | birch allergy market | vein illumination devices market


Recent Blog’s By DelveInsight:

Comments

Post a Comment

Popular posts from this blog

Raising the Bar: ADCs and Lung Cancer Treatment Breakthroughs

Image
  The ENHERTU Effect: A Closer Look at the Dynamic Duo Daiichi Sankyo and AstraZeneca Taking on HER2-mutant NSCLC Lung cancer remains one of the most challenging and prevalent forms of cancer. Within this landscape, innovative treatments are offering new hope. One such breakthrough is the collaboration between Daiichi Sankyo and AstraZeneca, which brings forth ENHERTU, an Antibody-Drug Conjugate (ADC). ENHERTU is making strides in targeting HER2-mutant Non-Small Cell Lung Cancer (NSCLC), a rare and challenging subset of the disease. The ENHERTU partnership aims to address this unmet medical need with a highly targeted approach. Dato-DXd vs. TRODELVY: The Battle of ADC Targeting TROP2 As the world of ADCs expands, another remarkable battle is brewing between Daiichi Sankyo's Dato-DXd and TRODELVY in their quest to target TROP2. TROP2, also known as CEACAM5, is an antigen overexpressed in various cancers, including endometrial cancer. Both ADCs hold the potential to transform the
Read more
Image
Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory pro
Read more